CoChat

Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice

Hu, Manli, Zhang, Dingran, Xu, Hongyang, Zhang, Yan, Shi, Hongjie, Huang, Xiaoli, Wang, Xinhui, Wu, Yan, Qi, Zhili · 2021 · Hepatology
Cited by 93

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background and Aims: NASH is becoming a leading cause of liver cirrhosis and HCC. Salidroside (p‐hydroxyphenethyl‐β‐D‐glucoside; SAL) has various biological and pharmacological activities, including anti‐inflammatory, ‐oxidant, and ‐cancer activities. However, the therapeutic effect and underlying molecular mechanism of SAL in NASH remain to be further clarified. Methods and Results: In this study, we found that SAL alleviated lipid accumulation and inflammatory response in primary hepatocytes after palmitic acid/oleic acid (PO) stimulation. In addition, SAL effectively prevented high‐fat/high‐cholesterol (HFHC)‐diet–induced NASH progression by regulating glucose metabolism dysregulation, insulin resistance, lipid accumulation, inflammation, and fibrosis. Mechanistically, integrated RNA‐sequencing and bioinformatic analysis showed that SAL promoted AMPK‐signaling pathway activation in vitro and in vivo, and this finding was further verified by determining the phosphorylation levels of AMPK. Furthermore, the protective effects of SAL on lipid accumulation and inflammation in hepatocytes and livers induced by PO or HFHC stimulation were blocked by AMPK interruption. Conclusions: Our studies demonstrate that SAL protects against metabolic‐stress–induced NASH progression through activation of AMPK signaling, indicating that SAL could be a potential drug component for NASH therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.32066

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 93

Metadata

Authors
Hu, M., Zhang, D., Xu, H., Zhang, Y., Shi, H., Huang, X., Wang, X., Wu, Y., & Qi, Z.
Venue
Hepatology
Published
2021-10-21
Volume
74
Issue
6
Pages
3056-3073
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W3184800199
Cited by
93
References
4
FWCI
8.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. https://app.cochat.ai/papers/10.1002/hep.32066
The paper
Hu, M., Zhang, D., Xu, H., Zhang, Y., Shi, H., Huang, X., Wang, X., Wu, Y., & Qi, Z. (2021). Salidroside Activates the AMP‐Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. Hepatology. https://doi.org/10.1002/hep.32066

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.